AKT1 and neoplasm: In addition, diosgenin activates tumor cell autophagy and apoptosis by inhibiting the phosphorylation of phosphoinositide 3-kinase, Akt, and the mammalian target of rapamycin, thereby decreasing signaling through this pathway [31].